Skip to main content
AvailableOncology

Tucaliv 150mg Tablet

By HETERO HEALTHCARE PVT LTD

150mg

Tucaliv 150mg Tablet

Tucaliv 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HER2-positive cancers. Tucatinib works by selectively blocking the activity of the HER2 protein, which is overexpressed in certain aggressive cancers such as advanced or metastatic HER2-positive breast cancer. By inhibiting this pathway, the medicine helps to slow disease progression, reduce tumour growth, and can improve patient outcomes. Tucaliv is prescribed as part of a specialist-led oncology treatment plan, often used in combination with other anticancer medicines under medical supervision. Dosage and treatment schedules are determined by the oncologist based on individual patient condition, disease stage, and response to therapy to ensure safety and effectiveness. Tucatinib is also indicated in combination with trastuzumab for certain metastatic colorectal cancers in selected patients.

Price

₹24,880.00 /bottle

₹45,000.00 /bottle

Save 45% off MRP

All prices are inclusive of taxes. Final commercial terms are confirmed on quote.

Dosage

150mg

Pack Size

1 Bottle of 60 Tablets

Active Ingredient / Salt

Tucatinib

Product Description

Tucaliv 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HER2-positive cancers. Tucatinib works by selectively blocking the activity of the HER2 protein, which is overexpressed in certain aggressive cancers such as advanced or metastatic HER2-positive breast cancer. By inhibiting this pathway, the medicine helps to slow disease progression, reduce tumour growth, and can improve patient outcomes. Tucaliv is prescribed as part of a specialist-led oncology treatment plan, often used in combination with other anticancer medicines under medical supervision. Dosage and treatment schedules are determined by the oncologist based on individual patient condition, disease stage, and response to therapy to ensure safety and effectiveness. Tucatinib is also indicated in combination with trastuzumab for certain metastatic colorectal cancers in selected patients.

Product Info

Price
₹24,880.00 /bottle
MRP
₹45,000.00 /bottle
Dosage
150mg
Pack Size
1 Bottle of 60 Tablets
Manufacturer
HETERO HEALTHCARE PVT LTD
Active Ingredient
Tucatinib
Category
Oncology

Key Benefits

  • Targets the HER2 pathway involved in specific advanced cancers
  • Helps slow progression of HER2-positive metastatic breast cancer
  • Can be used in combination with other targeted therapies for enhanced effectiveness
  • Oral tablet form allows patient-friendly daily administration
  • Supports specialist-guided oncology treatment plans
  • May improve outcomes in patients who have received prior anticancer therapy

Usage & Safety

Direction for Use

* Take orally with or without food as directed by your oncologist * Swallow the tablet whole; do not crush, chew, or split it * Do not alter dose or schedule without consulting your doctor * Complete the full course unless directed otherwise * Regular follow-ups recommended to monitor treatment response

Safety Information

* Common side effects may include diarrhoea, fatigue, nausea, rash, liver enzyme elevations, and decreased appetite based on class effects of tucatinib * Serious reactions may include liver problems and severe diarrhoea requiring medical attention * Not recommended during pregnancy or breastfeeding; effective contraception required * Regular monitoring of liver function and other laboratory tests is necessary * Avoid driving or operating machinery if dizziness, fatigue, or other side effects occur * Keep out of reach of children; dispose of unused medicine responsibly * Seek immediate medical attention if severe or unexpected symptoms occur

Allergy Information

* May contain standard excipients * Not suitable for individuals allergic to tucatinib or similar agents

Good to Know

* Manufactured under WHO‑GMP standards * Storage: Store below 30 °C in a dry place * Prescription‑only medicine requiring specialist supervision * Administered according to professional oncology guidelines * Indicated in combination with trastuzumab and capecitabine for treatment of certain advanced HER2-positive cancers as directed by a physic

Why Choose Tucaliv 150mg Tablet?

Authentic Product

We source Tucaliv 150mg Tablet through trusted pharmaceutical channels with an emphasis on authenticity and batch traceability.

Quality Control

Rigorous handling, compliant storage, and careful dispatch planning help protect product integrity.

Fast Delivery

Institutional quote handling and lane planning keep urgent requirements moving without avoidable delays.

Expert Support

Our team helps align pack, category, and procurement details before you finalize a commercial decision.

Alternative Medicines with Same Salt

These alternatives share the same active ingredient or linked molecule record. Please consult your healthcare provider before making any substitutions.

Intuca 150mg Tablet product image

Same salt alternative

Intuca 150mg Tablet

By Intas pharmaceutical pvt ltd · 150mg

Intuca 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HE…

₹4,980.00 /strip

View details
Tucanat 150mg Tablet product image

Same salt alternative

Tucanat 150mg Tablet

Natco Pharma Ltd · 150mg

Tucanat 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of H…

₹28,100.00 /bottle

View details
Tucaone 150mg Tablet product image

Same salt alternative

Tucaone 150mg Tablet

Msn Laboratories India pvt Ltd · 150mg

Tucaone 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of H…

₹5,999.00 /strip

View details

Related Oncology Products

Explore other products from the same category.

View all Oncology
Bracanat 150mg Tablet product image

Oncology

Bracanat 150mg Tablet

Natco Pharma Ltd · 150mg

₹4,400.00 /Bottle

View details
Ibyra 150mg Tablet product image

Oncology

Ibyra 150mg Tablet

Zydus Cadila · 150mg

₹6,800.00 /Bottle

View details
Intuca 150mg Tablet product image

Oncology

Intuca 150mg Tablet

By Intas pharmaceutical pvt ltd · 150mg

Intuca 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HE…

₹4,980.00 /strip

View details

More from HETERO HEALTHCARE PVT LTD

Explore other products from the same trusted manufacturer.

Lynza 150mg Tablet product image

HETERO HEALTHCARE PVT LTD

Lynza 150mg Tablet

HETERO HEALTHCARE PVT LTD · 150mg

₹4,365.00 /Bottle

View details

Ready to Order Tucaliv 150mg Tablet?

Get competitive pricing, institutional support, and confirmed availability for Tucaliv 150mg Tablet. Share quantity, location, and timeline and our team will respond with the right next step.